A cross-sectional epidemiological study of HBV, HCV, HDV and HEV prevalence in the SubCarpathian and South-Eastern regions of Romania

Journal of Gastrointestinal and Liver Diseases

Volumn 19, Issue 1, 2010, Pages 43-48

  Voiculescu, Mihai ^a   Iliescu, Laura ^a   Ionescu, Camelia ^a   Micu, Laurentiu ^a   Ismail, Gener ^a   Zilisteanu, Diana ^a   Radasan, Andreea ^b   Micu, Georgia ^a   Pertache, Ioana ^c  

^a FUNDENI CLINICAL INSTITUTE   (Romania)

^b University of Medicine and Pharmacy 'Carol Davila'

^c Health Statistics and Medical Documentation   (Romania)

Author keywords

Epidemiology; HBV; HCV; HDV; Hemodialysis; HEV; Risk factors; Seroprevalence

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; HEPATITIS C ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; VIRUS DNA; VIRUS RNA;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CHILD; CONTROLLED STUDY; DELTA AGENT HEPATITIS; EPIDEMIOLOGICAL DATA; FEMALE; HEMODIALYSIS; HEPATITIS B; HEPATITIS C; HEPATITIS E; HIGH RISK POPULATION; HUMAN; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; RISK FACTOR; ROMANIA; SEROPREVALENCE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ALANINE TRANSAMINASE; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DNA, VIRAL; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HEPATITIS D; HEPATITIS DELTA VIRUS; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; PREVALENCE; RENAL DIALYSIS; RISK ASSESSMENT; RISK FACTORS; RNA, VIRAL; ROMANIA; SEROEPIDEMIOLOGIC STUDIES; SEX FACTORS; YOUNG ADULT;

EID: 77951167364     PISSN: 18418724     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Santantonio T, Wiegand J, Gerlach JT. Acute hepatitis C: Current status and remaining challenges. J Hepatol 2008; 49: 625-633.
2. Esteban JI, Sauleda S, Quer J. The changing epidemiology of hepatitis C virus infection in Europe. J Hepatol 2008; 48: 148-152.
3. Gheorghe L, Iacob S, Csiki IE. Prevalence of hepatitis C in Romania: different from European rates? J Hepatol 2008; 49: 661-662.
4. Paquet C, Babes VT, Drucker J, Senemaud B, Dobrescu A. Viral hepatitis in Bucharest. Bull World Health Organ 1993; 71: 781-786.
5. Molnar GB, Popa S, Jebeleanu C, Damian C. Studiul prevalentei markerilor serici ai infectiei cu virusurile hepatitelor in anamneza epidemiologica a populatiei. Bacteriol Virusol Parazitol Epidemiol 1994; 30: 141-150.
6. Carreno V. Occult hepatitis C virus infection, a new form of hepatitis C. World J Gastroenterol 2006; 12: 6922-6925.
7. Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2007; 45: 507-539.
8. EASL. International Consensus Conference of Hepatitis B. 13-14 September 2002 Geneva, Switzerland. Consensus of statement (long version). J Hepatol 2003; 39 Supl. 1: S3-25.
9. Glantz SA. Primer of biostatistics. 4th ed. McGraw - Hill, New York 1997: 156-190.
10. Deming WE. Some theory of sampling. Dower Publ. Inc. New York, 1950: 1-9.
11. Anderson T W, Sclove SL. The statistical analysis of data. 2nd ed. Scientific Press: (Palo Alto, CA) 1986: 15-34.
12. Stanley S, Schor GP. Fundamentals of biostatistics. Putnam's Sons: New York 1968: 478-480.
13. Fabrizi F, Lunghi G, Ganeshan SV, Martin P, Messa P. Hepatitis C virus infection and the dialysis patients. Semin Dial 2007; 20: 416-422.
14. Gay N, Edmunds W, Bah E, Nelson C. Estimating the global burden of hepatitis B. World Health Organization, Department of Vaccines and Biologicals, Geneva 2001; 34: 349A.
15. Brechot C, Thiers V, Kremsdorf D, Nalpas B, Pol S, Paterlini-Brechot P. Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significan or purely "occult"? Hepatology 2001; 34: 194-203.
16. Hadziyannis SJ, Vassilopoulos D. Hepatitis B antigen-negative chronic hepatitis B. Hepatology 2001; 34: 617-624.
17. Allain JP. Epidemiology of Hepatitis B and genotypes. J Clinl Virol 2006; 36: S12-S17.
18. Ribeiro NR, Campos GS, Angelo AL, et al. Distribution of hepatitis B virus genotypes among patients with chronic infection. Liver Int 2006; 26: 634-642.
19. Turkish Association for the Study of Liver- Chronic Hepatitis B Guidelines. Turk J Gastroenterol 2008; 19: 207-230.
20. Gurol E, Saban C, Oral O, Cigdem A, Armagan A. Trend in hepatitis B and hepatitis C virus among blood donors over 16 years in Turkey. Eur J Epidemiol 2006; 21: 299-305.
21. Kondili L A, Chionne P, Costantino A, et al. Infection rate and spontaneous seroreversion of anti-hepatitis C virus during the natural course of hepatitis C virus infection in the general population. Gut 2002; 50: 693-696.
22. Hutchinson SJ, Goldberg DJ, King M, et al. Hepatitis C virus among childbearing women in Scotland: prevalence, deprivation, and diagnosis, Gut 2004; 53: 593-598.
23. Camarero C, Ramos N, Moreno A, Asensio A, Mateos ML, Roldan B. Hepatitis C virus infection acquired in childhood. Eur J Pediatr 2008; 167: 219-224.
24. Lopes EP, Gouveia EC, Albuquerque AC, et al. Determination of the cut-off value of serum alanine aminotransferase in pacients undergoing hemodialysis to identify biochemical activity in pacients with hepatitis C viremia. J Clin Virol 2006; 35: 298-302.
25. Meyers CM, Seeff LB, Stehman-Breen CO, Hoofnagle GH. Hepatitis C and renal disease: an update. Am J Kidney Dis 2003; 42: 631-657.
26. Widjaja D, Yarlagadda S, Singu BS, et al. Characteristics of patients with chronic hepatitis-B virus infection in an urban hospital. Natl Med Assoc 2007; 99: 384-388.
27. Burdick RA, Bragg-Gresham JL, Woods JD, et al. Patterns of hepatitis B prevalence and seroconversion in hemodialysis units from three continents: The DOPPS. Kidney Int 2003; 63: 2222-2229.
28. Vladutiu DS, Cosa A, Neamtu A, et al. Infection with hepatitis B and C virus in patients on maintenance dialysis in Romania and in former communist countries: yellow spots on a blank map? J Viral Hepat 2000; 7: 313-319.